NS · Healthcare

Medinova Diagnostic Services Ltd (526301)

Healthcare Services

Medinova Diagnostic Services Ltd (526301) is listed on NS in the Healthcare sector. Industry: Healthcare Services. As of 2026-07-10, reported market cap is $439.20M, P/E ratio is 41.12, net margin is 9.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 526301

Market cap

$439.20M

P/E ratio

41.12

Net margin

9.6%

Medinova Diagnostic Services Ltd (526301) — FAQ

What is Medinova Diagnostic Services Ltd's market cap?

Medinova Diagnostic Services Ltd (526301) has a reported market cap of $439.20M (data as of 2026-07-10).

What is 526301's P/E ratio?

The price-to-earnings (P/E) ratio for Medinova Diagnostic Services Ltd (526301) is 41.12 (data as of 2026-07-10).

Does Medinova Diagnostic Services Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Medinova Diagnostic Services Ltd (526301). Check the MyAverix Finance app for the latest dividend data.

What sector is Medinova Diagnostic Services Ltd in?

Medinova Diagnostic Services Ltd (526301) is classified in the Healthcare sector (Healthcare Services industry).

What exchange is 526301 listed on?

526301 is listed on NS.

What is Medinova Diagnostic Services Ltd's net margin?

Medinova Diagnostic Services Ltd (526301) reports a net margin of 9.6% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)